King Faisal Specialist Hospital & Research Centre (KFSHRC) has reaffirmed its leading role in advancing clinical research across Saudi Arabia, contributing 52% of all active clinical studies in the Kingdom by the end of 2024, out of a total of 470 studies, according to data from the Saudi National Institute for Health Research. This achievement highlights KFSHRC’s pivotal role in driving medical advancements and enhancing healthcare outcomes.
KFSHRC continues to lead in advanced clinical research by conducting high-impact studies across diverse medical fields. In 2023 alone, the hospital published more than 1,300 peer-reviewed scientific papers in prestigious international journals and secured 18 new patents, underscoring its commitment to evidence-based innovation and the development of cutting-edge therapeutic solutions.
The hospital also maintains active collaborations with leading academic and research institutions locally and internationally, fostering a robust research ecosystem that supports innovation and contributes to the ongoing improvement of healthcare quality. These efforts align with the goals of Saudi Vision 2030, which aims to position the Kingdom as a global leader in medical research and healthcare innovation.
It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa